Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. - Wikidata - awgldk - TriplyDB

Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women.

Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women.

http://www.wikidata.org/entity/Q34672882

about

A systematic review of randomized trials assessing human papillomavirus testing in cervical cancer screening Cervical excisional treatment of young women: a population-based study How to interpret the results of medical time series data analysis: Classical statistical approaches versus dynamic Bayesian network modeling.Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix.Cervical cytology screening among low-income, minority adolescents in New York City following the 2009 ACOG guidelines Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions.A cross sectional study of HPV type prevalence according to age and cytology Clinical application of DNA ploidy to cervical cancer screening: A review.From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice.Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection.HPV E6/E7 RNA in situ hybridization signal patterns as biomarkers of three-tier cervical intraepithelial neoplasia grade.c-myc copy number gain is a powerful prognosticator of disease outcome in cervical dysplasia Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females Carcinogenic HPV infection in the cervical squamo-columnar junction.Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice Cervical carcinoma rates among young females in the United States.Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections.Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.The detection of hTERC amplification using fluorescence in situ hybridization in the diagnosis and prognosis of cervical intraepithelial neoplasia: a case control study.Clinical Utility of Molecular Biomarkers in Cervical Squamous Intraepithelial Lesions in a Young Adult Population.HPV vaccines and cancer prevention, science versus activism.Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada.Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines.Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive.Six-year regression and progression of cervical lesions of different human papillomavirus viral loads in varied histological diagnoses.Screening adolescents and young women Answering human papillomavirus vaccine concerns; a matter of science and time.Updating the natural history of human papillomavirus and anogenital cancers See-and-Treat for High-Grade Cytology: Do Young Women Have Different Rates of High-Grade Histology?Impact of 2-, 4- and 9-valent HPV vaccines on morbidity and mortality from cervical cancer Compliance with cervical cancer screening and human papillomavirus testing guidelines among insured young women.National- and state-level impact and cost-effectiveness of nonavalent HPV vaccination in the United States HPV 16 Is Related to the Progression of Cervical Intraepithelial Neoplasia Grade 2: A Case Series Impact of Age at Conization on Obstetrical Outcome: A Case-Control Study Does CIN2 Have the Same Aggressive Potential As CIN3? A Secondary Analysis of High-Grade Cytology Recurrence in Women Treated with Cold-Coagulation Cervical Treatment.Current recommendations for cervical cancer screening: do they render the annual pelvic examination obsolete?Exploiting biospectroscopy as a novel screening tool for cervical cancer: towards a framework to validate its accuracy in a routine clinical setting.Factors influencing decisions about surgical treatment of cervical precancerous lesions.Worldwide incidence of cervical lesions: a systematic review.

P2860

Q26824878-894ACAD3-581D-45B8-9015-1E99ADB477C9 Q30407712-FC967390-6969-4E9D-A4FE-A92AB4683A9B Q31159691-09A225FD-3145-43E6-BB69-2F1BCAAE7310 Q33745439-6EC32FCB-A62F-4D53-AA12-7D3F52AB4AB1 Q33822258-EE64D456-0083-430E-9207-B2D11E1DF1A8 Q34141990-E368FBD6-699C-4B48-AD81-9C8186905E09 Q34535660-9A2B2C72-7B59-445E-96CD-766D995A3482 Q34567575-4CB774B7-EDB9-41D6-A2B2-29F2B673E45D Q34657755-0259DC6F-B3F5-4F2C-96E3-0DFDB068EAE3 Q34774870-22CD6C21-0B7C-44F0-8E8B-B767E452249B Q35039759-03DA4FBB-4020-4299-9D1D-94020B279DCF Q35119921-E707D5D6-52B8-4122-B9A9-3714F19E4B2C Q35176152-91E36273-67D7-4D0D-A215-C10E8D1FE8E7 Q35550810-ADE6BCE2-BDDF-4DA1-86B1-D4FF81D599B8 Q35688731-080D4F19-1303-4FF6-BBE0-95C43A720EC2 Q35738881-B3289F55-8E5F-494F-A5FF-92CAE687BD7E Q35966730-4A0BC215-1BC1-485A-9C39-3533CD988AD6 Q36023925-879EFC42-EBD9-446F-B185-C7105E918984 Q36159360-65A7D1A8-4D13-402D-9A6D-A28A63B4A53C Q36360128-D3D85D1E-E18B-412C-8C3E-1D7A54E15CD5 Q36404806-A36B235A-F0E7-4CA5-8CD3-2D223CDE1977 Q36591743-971973A7-C22B-43F4-88D2-1CA6D0800FAB Q36658811-BE195437-5FED-4BE3-829F-AFAD41A4B8F8 Q36739947-C969FBA5-52F5-404A-B1CC-A6DC3828E8C8 Q36740029-B69D627A-7D17-42E4-9AB4-055390DA1337 Q36794559-66D50802-202D-44E0-819B-1B09E37244E7 Q36903551-E192FB24-757F-4640-9DB5-43EA0FB5CE5A Q36952972-11E66F57-9010-437C-860A-D8BB82684606 Q36979148-889037F4-0867-4379-8FA2-F6C91FC58669 Q37037356-393F08D9-CDAC-4F67-A301-62E3EBA081E9 Q37135163-14197043-72D1-4229-BC5A-76ECFFDF031E Q37135167-95F17B7C-B1BF-413C-9F4B-A16AC53BD2A7 Q37173134-28F6B4A6-83D9-434B-9C93-F43566A150C0 Q37403002-0F0BAC49-A817-4AEA-9BF2-E4D0AA681B57 Q37722593-EBD7901F-5649-4210-8DF1-FECF3F8AC613 Q37740243-281CE86F-6EAD-4A49-AD49-31A3A3D59076 Q38074769-F070DF9A-A3D5-465C-A818-AFBA4006ABA9 Q38158188-354E7F24-000E-47AD-A2E8-D9B7B0005276 Q38190107-B2509982-428E-4690-BDB5-62CD4DC271E3 Q38216073-B08EE478-F48E-4BD1-BBE1-0119942B6C23

P2860

Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women.

http://www.wikidata.org/entity/Q34672882

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Rate of and risks for regressi ...... n adolescents and young women.

@ast

Rate of and risks for regressi ...... n adolescents and young women.

@en

Rate of and risks for regressi ...... n adolescents and young women.

@nl

type

label

Rate of and risks for regressi ...... n adolescents and young women.

@ast

Rate of and risks for regressi ...... n adolescents and young women.

@en

Rate of and risks for regressi ...... n adolescents and young women.

@nl

prefLabel

Rate of and risks for regressi ...... n adolescents and young women.

@ast

Rate of and risks for regressi ...... n adolescents and young women.

@en

Rate of and risks for regressi ...... n adolescents and young women.

@nl

P1433

Q34672882-7D854FAF-0B94-49AE-B854-3DBB5C9009D5

P1476

Q34672882-7B76E5F7-8A7D-4D89-88D9-F69ADF8D850E

P2093

Q34672882-13BD316B-E10C-4986-989B-28E5FA436996

Q34672882-3333C2F8-C50C-46BC-B54D-3A54AF7ABE71

Q34672882-33B282E3-3821-4D2E-81EB-52A29A2C6869

Q34672882-7F923641-EE60-40C4-AAD9-6C20C154198A

Q34672882-8FE7714E-3F77-4AA8-8E84-5B78C1B88225

Q34672882-A5B6572D-4701-4CCD-91F2-570786E8765A

Q34672882-B7ADF549-4833-4090-A134-3ECC4EA1A855

P2860

Q34672882-1D21660E-7130-4399-B269-4CF14F5E15B3

Q34672882-1FB298E8-694D-47EC-9345-7B69890631BE

Q34672882-2B7AB627-7281-4F91-8D1A-8338E4C62C6A

Q34672882-2DCEAA36-EFAB-40A6-A3F6-E86916B79BA5

Q34672882-337DF454-B0C1-4ADA-BD65-C3130DE2BF6F

Q34672882-3B287428-99E4-48B8-AA67-05A0D71F8F62

Q34672882-4AD31B17-5498-4D47-8695-9C758932415E

Q34672882-52462261-FBAB-4011-8BCA-E26D6E4BB3D4

Q34672882-5A9BC8A4-E651-4CD3-97BF-755B5822B991

Q34672882-5B8ECE08-0A23-4224-A9CE-366FC4DD3764

P304

Q34672882-82E6DB70-EF26-466D-890A-F979E6646820

P31

Q34672882-EDD2A6A0-7305-4D60-90B8-BF7E459A94B8

P356

Q34672882-514A7EDE-1B48-465D-98FA-1056B8BA60B7

P407

Q34672882-54E8BE1C-A47E-4DA2-961C-2FBC3630D709

P433

Q34672882-A05414CA-9501-4A69-8820-890C7310631E

P478

Q34672882-EC67487E-1735-4417-9ED4-EAFB0B5FD72C

P577

Q34672882-D404DED5-743B-41F0-BFA6-4133656ACF4D

P5875

Q34672882-2716D8B2-A938-4DB0-A564-97BC5DF480CC

P698

Q34672882-4314FAF1-0920-47C6-8A93-7591C0230AF0

P921

Q34672882-AAACEE54-63C7-454A-B533-43A4514C98BF

P932

Q34672882-8508538D-8950-4B12-98E0-D5BA0BD62FD4

P356

AOG.0B013E3181FE777F

P1433

Obstetrics and Gynecology

P1476

Rate of and risks for regressi ...... n adolescents and young women.

@en

P2093

Adaleen Powers

http://www.w3.org/2001/XMLSchema#string

Anna-Barbara Moscicki

http://www.w3.org/2001/XMLSchema#string

Charles Wibbelsman

http://www.w3.org/2001/XMLSchema#string

Sepideh Farhat

http://www.w3.org/2001/XMLSchema#string

Stephen Shiboski

http://www.w3.org/2001/XMLSchema#string

Teresa M Darragh

http://www.w3.org/2001/XMLSchema#string

Yifei Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation

2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ

Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data.

Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies.

Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model

The reproducibility of CIN diagnoses among different pathologists: data from histology reviews from a multicenter randomized study.

Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis

The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review.

Comparison of natural histories of human papillomavirus detected by clinician- and self-sampling.

Management of cervical intraepithelial neoplasia 2 in adolescent and young women.

P304

1373-1380

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/AOG.0B013E3181FE777F

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49630621

http://www.w3.org/2001/XMLSchema#string

P698

21099605

http://www.w3.org/2001/XMLSchema#string

P921

P932

3057366

http://www.w3.org/2001/XMLSchema#string